These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 9561203)
1. Sensitivity to inhibition and catalytic efficiency of HIV proteinase mutants. Wilson SI; Phylip LH; Gulnik SV; Mills JS; Bur D; Dunn BM; Kay J Adv Exp Med Biol; 1998; 436():85-9. PubMed ID: 9561203 [No Abstract] [Full Text] [Related]
2. Computer assisted evaluation of inhibitor sensitivity to HIV-1 PR mutants. Sussman F; Martínez LA; Villaverde MC Adv Exp Med Biol; 1998; 436():91-7. PubMed ID: 9561204 [No Abstract] [Full Text] [Related]
3. Amprenavir resistance imparted by the I50V mutation in HIV-1 protease can be suppressed by the N88S mutation. Lam E; Parkin NT Clin Infect Dis; 2003 Nov; 37(9):1273-4. PubMed ID: 14557976 [No Abstract] [Full Text] [Related]
4. Predicting drug-resistant mutations of HIV protease. Ishikita H; Warshel A Angew Chem Int Ed Engl; 2008; 47(4):697-700. PubMed ID: 18058968 [No Abstract] [Full Text] [Related]
5. HIV protease mutations leading to reduced inhibitor susceptibility. Korant B; Lu Z; Strack P; Rizzo C Adv Exp Med Biol; 1996; 389():241-5. PubMed ID: 8861017 [No Abstract] [Full Text] [Related]
8. Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance. Kozísek M; Cígler P; Lepsík M; Fanfrlík J; Rezácová P; Brynda J; Pokorná J; Plesek J; Grüner B; Grantz Sasková K; Václavíková J; Král V; Konvalinka J J Med Chem; 2008 Aug; 51(15):4839-43. PubMed ID: 18598016 [TBL] [Abstract][Full Text] [Related]
9. Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: a focused library approach. Shultz MD; Ham YW; Lee SG; Davis DA; Brown C; Chmielewski J J Am Chem Soc; 2004 Aug; 126(32):9886-7. PubMed ID: 15303839 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease. Chellappan S; Kairys V; Fernandes MX; Schiffer C; Gilson MK Proteins; 2007 Aug; 68(2):561-7. PubMed ID: 17474129 [TBL] [Abstract][Full Text] [Related]
11. Combining mutations in HIV-1 protease to understand mechanisms of resistance. Mahalingam B; Boross P; Wang YF; Louis JM; Fischer CC; Tozser J; Harrison RW; Weber IT Proteins; 2002 Jul; 48(1):107-16. PubMed ID: 12012342 [TBL] [Abstract][Full Text] [Related]
19. Comparative studies on inhibitors of HIV protease: a target for drug design. Jayaraman S; Shah K In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and impact of HIV-1 protease mutation L76V on lopinavir resistance. de Mendoza C; Garrido C; Corral A; Zahonero N; Soriano V AIDS; 2008 Jan; 22(2):311-3. PubMed ID: 18097236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]